Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000021300
JPRN-UMIN000021300
Completed
N/A

The study of the predictive factors for response to Tolvaptan in Liver cirrhosis patients with water retention - The study of the predictive factors for response to Tolvaptan in Liver cirrhosis patients with water retention

Hokkaido University Graduate School of Medicine0 sites30 target enrollmentMarch 3, 2016
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsiver cirrhosis with refractory water retention

Overview

Phase
N/A
Intervention
Not specified
Conditions
iver cirrhosis with refractory water retention
Sponsor
Hokkaido University Graduate School of Medicine
Enrollment
30
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 3, 2016
End Date
June 30, 2017
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Hokkaido University Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •(1\)The patients with allergy to Tolvaptan (2\)The patients who is difficult to take Tolvaptan (3\)The patients who is difficult to drink water (4\)The anuric patients (5\)Hypernatremia (6\)The pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials

Withdrawn
Phase 2
Identification of predictive factors for response to neo-adjuvant Sunitinib in patients with resectable hepatocellular carcinomahepatocellular carcinomaliver cancer1001981510019818
NL-OMON32387niversitair Medisch Centrum Groningen15
Active, Not Recruiting
N/A
Investigation to identify predictors of response to a treatment with montelukast
EUCTR2005-004115-29-DEResearch Institute for the prevention of allergy and airway diseases in childhood
Completed
N/A
Predictors of Non-response and Loss of Response in IBD Patients Treated With Anti-TNFInflammatory Bowel Disease
NCT01605188Evangelismos Hospital132
Recruiting
N/A
Research to identify factors that predict response to enzalutamide using biopsy tissues from castration-resistant prostate cancer.castration resistant prostate cancerprostate cancer, castration-resistant, enzalutamideD064129
JPRN-jRCTs051180140Akamatsu Shusuke340
Completed
N/A
Exploration of Predictive factors for response to Enzaltamide in bone metastasis of Prostate cancerBone metastasis of prostate cancer
JPRN-UMIN000018634Department of Urology, Juntendo University Graduate School of Medicine100